An interventional study of Coil embolization in Aneurysm, Ruptured and Intracranial Aneurysm, sponsored by Seoul National University Hospital. Terminated at 3 sites in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2025-07-25.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
Comparison of clinical and radiological outcomes between bare platinum coil group and second-generation hydrogel coils for treatment of ruptured intracranial aneurysms.
The investigators aimed to analyze whether the use of second-generation hydrogel coils for the treatment of ruptured intracranial aneurysms improves clinical and angiographic outcomes compared with the use of bare platinum coils.
29 studies on the registry are indexed under Aneurysm, Ruptured; 7 are open to participants now.
This study's enrollment of 68 is above the median of 33 across 16 interventional studies indexed under Aneurysm, Ruptured.
Browse Aneurysm, Ruptured studies →Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Treatment using second-generation hydrogel coils (had to constitute \> 50% of the total coil length) for ruptured cerebral aneurysms
Device: Coil embolization
Treatment using bare metal coil only for ruptured cerebral aneurysms
Device: Coil embolization
coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils
any recurrence rate after treatment
any recurrence rate at 12 months after coil embolization
Time frame: during 12 months after coil embolization
rate of retreatment during 12 months follow-up period
rate of retreatment during 12 months follow-up period
Time frame: rate of retreatment during 12 months follow-up period
packing density (%) after coil embolization
packing density (%) after coil embolization
Time frame: packing density (%) after coil embolization
Procedural complication
Procedural complication
Time frame: during coil embolization
delayed cerebral ischemia during 12-month follow-up period
delayed cerebral ischemia during 12-month follow-up period
Time frame: delayed cerebral ischemia during 12-month follow-up period
good clinical outcome (mRS score ≤ 2) at 12-month follow-up period
good clinical outcome (mRS score ≤ 2) at 12-month follow-up period
Time frame: good clinical outcome (mRS score ≤ 2) at 12-month follow-up period
rate of ventriculoperitoneal shunt during 12-month follow-up period
rate of ventriculoperitoneal shunt during 12-month follow-up period
Time frame: rate of ventriculoperitoneal shunt during 12-month follow-up period
coil's ease of manipulation
coil's ease of manipulation
Time frame: during coil embolization
Plan to share: No
This study is terminated, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →